Answers to these questions would essential to better direct therapies (CFTR modulators, anti-inflammatory and immune modulatory drugs, QS inhibitors, stem cells) aimed at resolving the wound repair defect associated to CF at the level of the airway epithelium. Here, CFTR is linked to cystic fibrosis.